VAPB and neurodegenerative disease: Thus, there appears to be different routes by which neurodegenerative disease insults can impact upon ER–mitochondria tethering via the VAPB–PTPIP51 interaction, some involving activation of GSK-3β and some such as we describe here for α-synuclein, involving binding to the tethering proteins.